The global Intravenous Immunoglobulin (IVIg) market is projected to reach US$ 15470 million by 2030 from an estimated US$ 10970 million in 2024, at a CAGR of 5.9% during 2024 and 2030.

Intravenous Immunoglobulin (IVIg) Market

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin (IVIg), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin (IVIg).

The Intravenous Immunoglobulin (IVIg) market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Immunoglobulin (IVIg) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravenous Immunoglobulin (IVIg) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.

Market Segmentation

Scope of Intravenous Immunoglobulin (IVIg) Market Report

Report Metric	Details
Report Name	Intravenous Immunoglobulin (IVIg) Market
Accounted market size in 2024	an estimated US$ 10970 million
Forecasted market size in 2030	US$ 15470 million
CAGR	5.9%
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	IVIg Liquid IVIg Powder
Segment by Application	Immunodeficiency Autoimmune Disease Acute Infection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intravenous Immunoglobulin (IVIg) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Immunoglobulin (IVIg) sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Intravenous Immunoglobulin (IVIg) Market growing?

Ans: The Intravenous Immunoglobulin (IVIg) Market witnessing a CAGR of 5.9% during the forecast period 2024-2030.

What is the Intravenous Immunoglobulin (IVIg) Market size in 2030?

Ans: The Intravenous Immunoglobulin (IVIg) Market size in 2030 will be US$ 15470 million.

What is the market share of major companies in Intravenous Immunoglobulin (IVIg) Market?

Ans: Global top four manufacturers hold a share above 65%.

What is the Intravenous Immunoglobulin (IVIg) Market share by region?

Ans: North America is the largest market, with a share about 45%.

Who are the main players in the Intravenous Immunoglobulin (IVIg) Market report?

Ans: The main players in the Intravenous Immunoglobulin (IVIg) Market are Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang

What are the Application segmentation covered in the Intravenous Immunoglobulin (IVIg) Market report?

Ans: The Applications covered in the Intravenous Immunoglobulin (IVIg) Market report are Immunodeficiency, Autoimmune Disease, Acute Infection

What are the Type segmentation covered in the Intravenous Immunoglobulin (IVIg) Market report?

Ans: The Types covered in the Intravenous Immunoglobulin (IVIg) Market report are IVIg Liquid, IVIg Powder

1 Study Coverage

1.1 Intravenous Immunoglobulin (IVIg) Product Introduction

1.2 Market by Type

1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 IVIg Liquid

1.2.3 IVIg Powder

1.3 Market by Application

1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Immunodeficiency

1.3.3 Autoimmune Disease

1.3.4 Acute Infection

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts

2.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2019-2030

2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales 2019-2030

2.2 Intravenous Immunoglobulin (IVIg) Market Size by Region: 2023 Versus 2030

2.3 Intravenous Immunoglobulin (IVIg) Sales by Region (2019-2030)

2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2019-2024

2.3.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2025-2030)

2.3.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2019-2030)

2.4 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Region (2025-2030)

2.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2019-2024

2.4.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2025-2030)

2.4.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2019-2030)

3 Global Intravenous Immunoglobulin (IVIg) by Manufacturers

3.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Sales

3.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2019-2024)

3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer (2019-2024)

3.2 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Revenue

3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2019-2024)

3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturer (2019-2024)

3.3 Global Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2019-2024)

3.4 Competitive Landscape

3.4.1 Key Intravenous Immunoglobulin (IVIg) Manufacturers Covered: Ranking by Revenue

3.4.2 Global Intravenous Immunoglobulin (IVIg) Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.4.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution, Product Type

3.5.1 Intravenous Immunoglobulin (IVIg) Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Intravenous Immunoglobulin (IVIg) Product Type

3.5.3 Date of International Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 Baxter

4.1.1 Baxter Company Information

4.1.2 Baxter Description, Business Overview

4.1.3 Baxter Intravenous Immunoglobulin (IVIg) Products Offered

4.1.4 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.1.5 Baxter Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.1.6 Baxter Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.1.7 Baxter Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.1.8 Baxter Recent Developments

4.2 Grifols

4.2.1 Grifols Company Information

4.2.2 Grifols Description, Business Overview

4.2.3 Grifols Intravenous Immunoglobulin (IVIg) Products Offered

4.2.4 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.2.5 Grifols Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.2.6 Grifols Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.2.7 Grifols Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.2.8 Grifols Recent Developments

4.3 CSL

4.3.1 CSL Company Information

4.3.2 CSL Description, Business Overview

4.3.3 CSL Intravenous Immunoglobulin (IVIg) Products Offered

4.3.4 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.3.5 CSL Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.3.6 CSL Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.3.7 CSL Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.3.8 CSL Recent Developments

4.4 Octapharma

4.4.1 Octapharma Company Information

4.4.2 Octapharma Description, Business Overview

4.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered

4.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.4.5 Octapharma Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.4.6 Octapharma Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.4.7 Octapharma Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.4.8 Octapharma Recent Developments

4.5 Biotest

4.5.1 Biotest Company Information

4.5.2 Biotest Description, Business Overview

4.5.3 Biotest Intravenous Immunoglobulin (IVIg) Products Offered

4.5.4 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.5.5 Biotest Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.5.6 Biotest Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.5.7 Biotest Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.5.8 Biotest Recent Developments

4.6 Kedrion

4.6.1 Kedrion Company Information

4.6.2 Kedrion Description, Business Overview

4.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered

4.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.6.5 Kedrion Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.6.6 Kedrion Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.6.7 Kedrion Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.6.8 Kedrion Recent Development

4.7 Hualan Bio

4.7.1 Hualan Bio Company Information

4.7.2 Hualan Bio Description, Business Overview

4.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered

4.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.7.5 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.7.6 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.7.7 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.7.8 Hualan Bio Recent Development

4.8 CNBG

4.8.1 CNBG Company Information

4.8.2 CNBG Description, Business Overview

4.8.3 CNBG Intravenous Immunoglobulin (IVIg) Products Offered

4.8.4 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.8.5 CNBG Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.8.6 CNBG Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.8.7 CNBG Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.8.8 CNBG Recent Development

4.9 Shanghai RAAS

4.9.1 Shanghai RAAS Company Information

4.9.2 Shanghai RAAS Description, Business Overview

4.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered

4.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.9.5 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.9.6 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.9.7 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.9.8 Shanghai RAAS Recent Development

4.10 CBPO

4.10.1 CBPO Company Information

4.10.2 CBPO Description, Business Overview

4.10.3 CBPO Intravenous Immunoglobulin (IVIg) Products Offered

4.10.4 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.10.5 CBPO Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.10.6 CBPO Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.10.7 CBPO Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.10.8 CBPO Recent Development

4.11 LFB Group

4.11.1 LFB Group Company Information

4.11.2 LFB Group Description, Business Overview

4.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Products Offered

4.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.11.5 LFB Group Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.11.6 LFB Group Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.11.7 LFB Group Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.11.8 LFB Group Recent Development

4.12 BPL

4.12.1 BPL Company Information

4.12.2 BPL Description, Business Overview

4.12.3 BPL Intravenous Immunoglobulin (IVIg) Products Offered

4.12.4 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.12.5 BPL Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.12.6 BPL Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.12.7 BPL Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.12.8 BPL Recent Development

4.13 Sichuan Yuanda Shuyang

4.13.1 Sichuan Yuanda Shuyang Company Information

4.13.2 Sichuan Yuanda Shuyang Description, Business Overview

4.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Products Offered

4.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)

4.13.5 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales by Product in 2023

4.13.6 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales by Application in 2023

4.13.7 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023

4.13.8 Sichuan Yuanda Shuyang Recent Development

5 Breakdown Data by Type

5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030)

5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)

5.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2025-2030)

5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2030)

5.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2019-2030)

5.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2024)

5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2025-2030)

5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2019-2030)

5.3 Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030)

6.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)

6.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2025-2030)

6.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2030)

6.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2019-2030)

6.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2024)

6.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2025-2030)

6.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2019-2030)

6.3 Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Application (2019-2030)

7 North America

7.1 North America Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2019-2030

7.2 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country

7.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)

7.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)

7.3 North America Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)

7.4 North America Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Region

8.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2019-2030)

8.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2019-2030)

8.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)

8.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)

9 Europe

9.1 Europe Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2019-2030

9.2 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country

9.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)

9.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)

9.3 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)

9.4 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)

10 Latin America

10.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2019-2030

10.2 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country

10.2.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)

10.2.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)

10.3 Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)

10.4 Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country

11.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)

11.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)

11.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)

11.4 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Intravenous Immunoglobulin (IVIg) Supply Chain Analysis

12.2 Intravenous Immunoglobulin (IVIg) Key Raw Materials and Upstream Suppliers

12.3 Intravenous Immunoglobulin (IVIg) Clients Analysis

12.4 Intravenous Immunoglobulin (IVIg) Sales Channel and Sales Model Analysis

12.4.1 Intravenous Immunoglobulin (IVIg) Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Intravenous Immunoglobulin (IVIg) Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Intravenous Immunoglobulin (IVIg) Distributors

13 Market Dynamics

13.1 Intravenous Immunoglobulin (IVIg) Industry Trends

13.2 Intravenous Immunoglobulin (IVIg) Market Drivers

13.3 Intravenous Immunoglobulin (IVIg) Market Challenges

13.4 Intravenous Immunoglobulin (IVIg) Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Sichuan Yuanda Shuyang

List of Tables

Table 1. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Manufacturers of IVIg Liquid

Table 3. Major Manufacturers of IVIg Powder

Table 4. Global Intravenous Immunoglobulin (IVIg) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (US$ Million): 2023 VS 2030

Table 6. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2019-2024) & (K Bottle)

Table 7. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2025-2030) & (K Bottle)

Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 10. Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2019-2024) & (K Bottle)

Table 11. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturer (2019-2024)

Table 12. Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2019-2024) & (US$ Million)

Table 13. Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturer (2019-2024)

Table 14. Key Manufacturers Intravenous Immunoglobulin (IVIg) Price (2019-2024) & (USD/Bottle)

Table 15. Ranking of Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Revenue (US$ Million) in 2023

Table 16. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 17. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2023)

Table 18. Intravenous Immunoglobulin (IVIg) Manufacturers Manufacturing Base Distribution and Headquarters

Table 19. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type

Table 20. Date of International Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Baxter Company Information

Table 23. Baxter Description and Business Overview

Table 24. Baxter Intravenous Immunoglobulin (IVIg) Product

Table 25. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 26. Baxter Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 27. Baxter Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 28. Baxter Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 29. Baxter Recent Development

Table 30. Grifols Company Information

Table 31. Grifols Description and Business Overview

Table 32. Grifols Intravenous Immunoglobulin (IVIg) Product

Table 33. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 34. Grifols Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 35. Grifols Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 36. Grifols Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 37. Grifols Recent Development

Table 38. CSL Company Information

Table 39. CSL Description and Business Overview

Table 40. CSL Intravenous Immunoglobulin (IVIg) Product

Table 41. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 42. CSL Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 43. CSL Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 44. CSL Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 45. CSL Recent Development

Table 46. Octapharma Company Information

Table 47. Octapharma Description and Business Overview

Table 48. Octapharma Intravenous Immunoglobulin (IVIg) Product

Table 49. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 50. Octapharma Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 51. Octapharma Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 52. Octapharma Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 53. Octapharma Recent Development

Table 54. Biotest Company Information

Table 55. Biotest Description and Business Overview

Table 56. Biotest Intravenous Immunoglobulin (IVIg) Product

Table 57. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 58. Biotest Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 59. Biotest Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 60. Biotest Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 61. Biotest Recent Development

Table 62. Kedrion Company Information

Table 63. Kedrion Description and Business Overview

Table 64. Kedrion Intravenous Immunoglobulin (IVIg) Product

Table 65. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 66. Kedrion Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 67. Kedrion Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 68. Kedrion Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 69. Kedrion Recent Development

Table 70. Hualan Bio Company Information

Table 71. Hualan Bio Description and Business Overview

Table 72. Hualan Bio Intravenous Immunoglobulin (IVIg) Product

Table 73. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 74. Hualan Bio Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 75. Hualan Bio Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 76. Hualan Bio Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 77. Hualan Bio Recent Development

Table 78. CNBG Company Information

Table 79. CNBG Description and Business Overview

Table 80. CNBG Intravenous Immunoglobulin (IVIg) Product

Table 81. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 82. CNBG Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 83. CNBG Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 84. CNBG Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 85. CNBG Recent Development

Table 86. Shanghai RAAS Company Information

Table 87. Shanghai RAAS Description and Business Overview

Table 88. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product

Table 89. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 90. Shanghai RAAS Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 91. Shanghai RAAS Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 92. Shanghai RAAS Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 93. Shanghai RAAS Recent Development

Table 94. CBPO Company Information

Table 95. CBPO Description and Business Overview

Table 96. CBPO Intravenous Immunoglobulin (IVIg) Product

Table 97. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 98. CBPO Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 99. CBPO Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 100. CBPO Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 101. CBPO Recent Development

Table 102. LFB Group Company Information

Table 103. LFB Group Description and Business Overview

Table 104. LFB Group Intravenous Immunoglobulin (IVIg) Product

Table 105. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 106. LFB Group Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 107. LFB Group Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 108. LFB Group Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 109. LFB Group Recent Development

Table 110. BPL Company Information

Table 111. BPL Description and Business Overview

Table 112. BPL Intravenous Immunoglobulin (IVIg) Product

Table 113. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 114. BPL Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 115. BPL Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 116. BPL Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 117. BPL Recent Development

Table 118. Sichuan Yuanda Shuyang Company Information

Table 119. Sichuan Yuanda Shuyang Description and Business Overview

Table 120. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product

Table 121. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 122. Sichuan Yuanda Shuyang Sales Proportion of Intravenous Immunoglobulin (IVIg) by Product in 2023

Table 123. Sichuan Yuanda Shuyang Sales Proportion of Intravenous Immunoglobulin (IVIg) by Application in 2023

Table 124. Sichuan Yuanda Shuyang Sales Proportion of Intravenous Immunoglobulin (IVIg) by Geographic Area in 2023

Table 125. Sichuan Yuanda Shuyang Recent Development

Table 126. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024) & (K Bottle)

Table 127. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2025-2030) & (K Bottle)

Table 128. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2024) & (US$ Million)

Table 129. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 130. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024) & (K Bottle)

Table 131. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2025-2030) & (K Bottle)

Table 132. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2024) & (US$ Million)

Table 133. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 134. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024) & (K Bottle)

Table 135. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2025-2030) & (K Bottle)

Table 136. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2024) & (US$ Million)

Table 137. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2025-2030) & (US$ Million)

Table 138. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024) & (K Bottle)

Table 139. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024) & (K Bottle)

Table 140. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2019-2024) & (K Bottle)

Table 141. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2025-2030) & (K Bottle)

Table 142. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2019-2030) & (US$ Million)

Table 143. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2025-2030) & (US$ Million)

Table 144. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024) & (K Bottle)

Table 145. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024) & (K Bottle)

Table 146. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024) & (K Bottle)

Table 147. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2025-2030) & (K Bottle)

Table 148. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2024) & (US$ Million)

Table 149. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2025-2030) & (US$ Million)

Table 150. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024) & (K Bottle)

Table 151. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024) & (K Bottle)

Table 152. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024) & (K Bottle)

Table 153. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2025-2030) & (K Bottle)

Table 154. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2024) & (US$ Million)

Table 155. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2025-2030) & (US$ Million)

Table 156. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024) & (K Bottle)

Table 157. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024) & (K Bottle)

Table 158. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024) & (K Bottle)

Table 159. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2025-2030) & (K Bottle)

Table 160. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2024) & (US$ Million)

Table 161. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2025-2030) & (US$ Million)

Table 162. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024) & (K Bottle)

Table 163. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024) & (K Bottle)

Table 164. Intravenous Immunoglobulin (IVIg) Key Raw Materials, Industry Status and Trend

Table 165. Intravenous Immunoglobulin (IVIg) Key Raw Materials and Upstream Suppliers

Table 166. Intravenous Immunoglobulin (IVIg) Clients Status and Trend

Table 167. Intravenous Immunoglobulin (IVIg) Typical Clients

Table 168. Intravenous Immunoglobulin (IVIg) Distributors

Table 169. Intravenous Immunoglobulin (IVIg) Market Trends

Table 170. Intravenous Immunoglobulin (IVIg) Market Drivers

Table 171. Intravenous Immunoglobulin (IVIg) Market Challenges

Table 172. Intravenous Immunoglobulin (IVIg) Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

List of Figures

Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture

Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2023 & 2030

Figure 3. IVIg Liquid Product Picture

Figure 4. IVIg Powder Product Picture

Figure 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2023 & 2030

Figure 6. Immunodeficiency Examples

Figure 7. Autoimmune Disease Examples

Figure 8. Acute Infection Examples

Figure 9. Intravenous Immunoglobulin (IVIg) Report Years Considered

Figure 10. Global Intravenous Immunoglobulin (IVIg) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Intravenous Immunoglobulin (IVIg) Market Size 2019-2030 (US$ Million)

Figure 12. Global Intravenous Immunoglobulin (IVIg) Sales 2019-2030 (K Bottle)

Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2019-2030)

Figure 14. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2019-2030)

Figure 15. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturer in 2023

Figure 16. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 17. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2019-2030)

Figure 18. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2019-2030)

Figure 19. Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Type (2019-2024) & (USD/Bottle)

Figure 20. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2019-2030)

Figure 21. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Application (2019-2030)

Figure 22. Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Application (2019-2024) & (USD/Bottle)

Figure 23. North America Intravenous Immunoglobulin (IVIg) Revenue 2019-2030 (US$ Million)

Figure 24. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2024)

Figure 25. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2024)

Figure 26. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue 2019-2030 (US$ Million)

Figure 27. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2019-2030)

Figure 28. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2019-2030)

Figure 29. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2024)

Figure 30. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2024)

Figure 31. Europe Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 32. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2019-2030)

Figure 33. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2019-2030)

Figure 34. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2024)

Figure 35. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2024)

Figure 36. Latin America Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 37. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2019-2030)

Figure 38. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2019-2024)

Figure 39. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2024)

Figure 40. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2024)

Figure 41. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 42. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2019-2030)

Figure 43. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2019-2030)

Figure 44. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2024)

Figure 45. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2024)

Figure 46. Intravenous Immunoglobulin (IVIg) Supply Chain (Upstream and Downstream Market)

Figure 47. Global Production Market Share of Intravenous Immunoglobulin (IVIg) Raw Materials by Region in 2023

Figure 48. Intravenous Immunoglobulin (IVIg) Distribution Channels

Figure 49. Global Intravenous Immunoglobulin (IVIg) Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 50. Global Intravenous Immunoglobulin (IVIg) Percentage 2019-2030: Online Sales VS Offline Sales

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions